Circulants Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Circulants's estimated annual revenue is currently $14.6M per year.(i)
  • Circulants's estimated revenue per employee is $145,000

Employee Data

  • Circulants has 101 Employees.(i)
  • Circulants grew their employee count by 6% last year.

Circulants's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Principal - Solution & Service DeliveryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M294%N/AN/A
#2
$43.4M2728%N/AN/A
#3
$14.1M9711%N/AN/A
#4
$1460M82917%$1.1BN/A
#5
$310M152720%N/AN/A
#6
$194.1M956-5%N/AN/A
#7
$223.9M1080-33%$101.6MN/A
#8
$581.3M27089%$253.1MN/A
#9
$716.2M35282%N/AN/A
#10
$801.4M394852%N/AN/A
Add Company

What Is Circulants?

Circulant offers cloud based operational Platform 'O' to pharma companies and enables Commercial and Development Operations team to rapidly on-board, manage, and govern data for insightful analytics and better decision making. At Circulant Solutions Inc., we believe that technology should support and enhance your organization's success, not constrain it. With our wide range of best-in-class services, we provide customized solutions that fit your unique business needs. We're committed to excel at our job so that you can focus on doing yours.

keywords:N/A

N/A

Total Funding

101

Number of Employees

$14.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Circulants News

2022-04-20 - Covid - BA.4, BA.5 : les nouveaux variants désormais sous haute surveillance, la situation en France ce 29 avr

La situation en France en termes de variants circulants est aujourd'hui stable, avec une dominance du variant Omicron.

2022-04-20 - COVID-19 EN BOURGOGNE-FRANCHE-COMTE La lente ...

Ce test contribue à la surveillance nationale et internationale des variants circulants sur notre territoire et permet de détecter...

2022-04-17 - Croissance énorme du marché des biomarqueurs circulants d ...

Croissance énorme du marché des biomarqueurs circulants d'ici 2029 |GE Healthcare, Agilent Technologies, Epigenomics AG · Paris (France) –...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.2M1015%N/A
#2
$25.4M101-8%$1.5M
#3
$26.1M1037%N/A
#4
$29.9M1037%N/A
#5
$26.2M1087%N/A